BFEB Performance — Innovator U.S. Equity Buffer ETF - February
Data updated: 2026-09-28
BFEB returned +8.69% year to date and +16.33% over one year to Jul 2026. Annualised returns are +14.82% over 3 years and +11.40% over 5 years. Against its US Blend category average the fund came out ahead over three years but behind over one: $100 invested three years ago grew to $151, against $147 for the category, and to $116 over one year, against $120. Volatility over the past three years was 8.94% a year. In the 12 months to Jul 2026 the fund took in a net $19.3M, and assets reached $253.94M.
BFEB Growth of $100
What $100 invested in Innovator U.S. Equity Buffer ETF - February grew to, compounded from monthly returns reported on SEC Form N-PORT, against the US Blend category average over the same months.
| Period | BFEB | Category average |
|---|---|---|
| 1 year (Aug 2025 – Jul 2026) | $116 | $120 |
| 3 years (Aug 2023 – Jul 2026) | $151 | $147 |
| 5 years (Aug 2021 – Jul 2026) | $172 | $143 |
| Since data start (Feb 2020 – Jul 2026) | $216 | $169 |
BFEB Trailing Returns
Total returns to Jul 2026, from SEC N-PORT.
| Period | Total return |
|---|---|
| YTD | +8.69% |
| 1 year | +16.33% |
| 3 years (annualised) | +14.82% |
| 5 years (annualised) | +11.40% |
BFEB Annual Returns
Calendar-year total returns of Innovator U.S. Equity Buffer ETF - February, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2026 (Jan–Jul) | +8.69% |
| 2025 | +12.91% |
| 2024 | +17.50% |
| 2023 | +22.49% |
| 2022 | −6.64% |
| 2021 | +17.93% |
| 2020 (Feb–Dec) | +10.96% |
BFEB Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | +2.1% | −0.4% | −3.5% | +7.3% | +3.0% | −0.2% | +0.5% | — | — | — | — | — |
| 2025 | +0.9% | −0.9% | −3.8% | −0.6% | +4.6% | +3.6% | +1.8% | +1.6% | +2.3% | +1.2% | +0.8% | +0.9% |
| 2024 | +2.0% | +3.1% | +1.9% | −2.0% | +3.5% | +1.9% | +0.7% | +1.6% | +0.9% | 0.0% | +2.4% | +0.3% |
| 2023 | +5.9% | −2.0% | +2.7% | +1.6% | +0.4% | +4.9% | +2.3% | −0.8% | −3.8% | −1.8% | +7.6% | +4.1% |
| 2022 | +0.3% | −2.2% | +2.5% | −6.2% | +0.7% | −5.5% | +6.3% | −2.6% | −6.3% | +6.1% | +4.3% | −3.0% |
| 2021 | +1.0% | +1.8% | +3.9% | +3.0% | +0.8% | +1.4% | +0.8% | +1.2% | −1.5% | +2.9% | −0.4% | +1.9% |
| 2020 | — | −5.8% | −9.5% | +9.3% | +4.0% | +0.6% | +4.0% | +3.8% | −1.9% | −0.9% | +6.7% | +1.7% |
BFEB Risk
Risk measures from monthly returns over Aug 2023 – Jul 2026.
- 3-year volatility (annualised): 8.94%
- 3-year Sharpe ratio: 1.15 (vs 4.5% risk-free rate)
- Best month: +7.62% (Nov 2023)
- Worst month: −3.82% (Mar 2025)
BFEB Fund Flows
Monthly money in and out of Innovator U.S. Equity Buffer ETF - February, from SEC Form N-PORT.
- 12-month net flow: $19.3M
- 12-month gross sales (incl. reinvestments): $84.7M
- Sales ÷ redemptions: 1.29×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Jul 2026 | $0 | $0 | $0 |
| Jun 2026 | $15.8M | $2.6M | $13.2M |
| May 2026 | $0 | $2.6M | −$2.6M |
| Apr 2026 | $1.3M | $0 | $1.3M |
| Mar 2026 | $7.3M | $2.3M | $4.9M |
| Feb 2026 | $55.6M | $1.2M | $54.4M |
| Jan 2026 | $1.2M | $1.2M | −$2K |
| Dec 2025 | $3.6M | $3.6M | −$35K |
| Nov 2025 | $0 | $29.7M | −$29.7M |
| Oct 2025 | $0 | $7.1M | −$7.1M |
| Sep 2025 | $0 | $2.3M | −$2.3M |
| Aug 2025 | $0 | $12.7M | −$12.7M |
BFEB Assets Under Management
Net assets of Innovator U.S. Equity Buffer ETF - February by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2026-07-31 | $253.94M |
| 2026-04-30 | $235.61M |
| 2026-01-31 | $167.68M |
| 2025-10-31 | $191.40M |
| 2025-07-31 | $203.48M |
| 2025-04-30 | $186.51M |
| 2025-01-31 | $119.60M |
| 2024-10-31 | $131.17M |
| 2024-07-31 | $215.99M |
| 2024-04-30 | $217.82M |
| 2024-01-31 | $91.73M |
| 2023-10-31 | $99.93M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.